Navigation Links
Dormant stem cells for emergencies
Date:12/4/2008

lls for the first time and, thus, to treat the disease much more effectively by destroying the supply basis."

In a second article*, Dr. Elisa Laurenti from Trumpp's team shows that the two cancer genes c-Myc and N-Myc play a vital role in the functioning of stem cells. The two genes provide the blueprints for what are called transcription factors, which in turn regulate the activity of other genes and are overactive particularly in cancer cells. If both c-Myc and N-Myc are switched off at the same time in mice, the animals quickly start suffering from a general lack of blood cells and quickly die.

The two genes are not only responsible for survival of nearly all blood cells, but they also jointly control the two prime characteristics of stem cells the capability of self-renewal and the potential to produce differentiated blood cells. This result is not only relevant for our understanding of stem cells, but it also explains the damage that can be caused by overactive Myc genes. Trumpp explains: "In tumors, too, c-Myc and N-Myc are presumably responsible for the self-renewal of cancer stem cells and, thus, for uncontrolled growth."


'/>"/>

Contact: Dr. Sibylle Kohlstaedt
s.kohlstaedt@dkfz.de
Helmholtz Association of German Research Centres
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Immune system can drive cancers into dormant state
2. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
3. Brain cells work differently than previously thought
4. Embryonic Stem Cells Repair Human Heart
5. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
6. Circulating fats kill transplanted pancreas cells, study shows
7. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
8. Melanoma drug revs immune cells but cancer cells ignore it
9. Scientists explain how insulin secreting cells maintain their glucose sensitivity
10. Embryonic stem cells used to grow cartilage
11. Molecular probe paints cancer cells in living animals, Stanford researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 2015 Cambia Health Solutions and ... new, interactive Affordable Care Act (ACA) training course ... called “Affordable Care Act Expert Series, Large Group ... and consultative insights necessary to effectively engage and ... impacts of the ACA. , The interactive, experience-based ...
(Date:6/1/2015)... For years, facial plastic surgery demands ... like one would request a hairstyle, patients would use ... and more to illustrate their adaptation of choice. However, ... ushering in a new era of aesthetic envy – ... Rizk, MD, FACS notes that since the explosion of ...
(Date:6/1/2015)... Listen to Volvo’s Director of Connectivity Strategy, Martin ... granular data to create better customer oriented services. Flanking ... Josep Celaya Gonzalez, CIO at MAPFRE, and Silvan Rath, ... insurer, MAPFRE are well versed in capturing complex data ... driver. Award winning start-up ParkTAG offer an exciting new ...
(Date:6/1/2015)... A University of Texas at ... proteins that activate protein degradation, which helps to ... , The study published April 3rd in ... rats 2-3 months of age who performed resistance ... either whey protein (.4g/kg), low-dose Sustamine (.1g/kg), high-dose ...
(Date:6/1/2015)... June 01, 2015 Kurbo Health , ... children and teens, announced today it has added in-app ... for kids and teens to eat smart and reach their ... their coaches via text message and phone or video calls, ... through their in-app chat window. For paid users, they will ...
Breaking Medicine News(10 mins):Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3Health News:Instagram Filters Launch New Facial Plastic Surgery Trend 2Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 3Health News:Kurbo, First Mobile Weight Loss Program for Children and Teens, Enhances Coaching with New iOS In-App Chat and Messaging from Coaches 2
... 2011 Egocentric, self-centred, and insensitive to the needs ... with severe traumatic brain injury (TBI) and have been ... the capacity to recognise and understand the emotions of ... more common, and resulting empathy deficits can have negative ...
... Maryland, June 28, 2011 Nurses on a surgical ... center cut bloodstream infections to zero and saved more ... of Maryland Medical Center SICU sustained a rate of ... period, eliminating 14 CLABSIs and saving 2-3 lives when ...
... from Wayne State University, and her mentor, Lisa J. Rapport, ... Liberal Arts and Sciences, found that if traumatic brain injury ... help them rehabilitate. The study was recently published in ... disruption of normal brain function after a head injury and ...
... Americans and the rest of the nation have been ... blacks who identify as members of the Seventh-day Adventist ... the average American. Researchers point to certain lifestyle behaviors ... was conducted at Loma Linda University as part of ...
... today,s society where access to media is ever present, many ... children and how media consumption can potentially affect them. Two ... and Dr. Michelle M. Garrison, PhD of Seattle Children,s Research ... media usage can lead to depression in college students and ...
... battle to lose inches or at least stay the same, ... 25 and 27 at the American Diabetes Association,s Scientific Sessions ... Epidemiologists from the School of Medicine at The ... showing that diet soft drink consumption is associated with increased ...
Cached Medicine News:Health News:Lack of empathy following traumatic brain injury linked to reduced responsiveness to anger 2Health News:Intensive, hands-on effort reduces bloodstream infections in critically ill patients 2Health News:Religion benefits traumatic brain injury victims, Wayne State University research finds 2Health News:Black members of Adventist church defy health disparities, study shows 2Health News:Studies examine impact of media use among youth, recommend preventative measures 2Health News:Studies examine impact of media use among youth, recommend preventative measures 3Health News:Related studies point to the illusion of the artificial 2Health News:Related studies point to the illusion of the artificial 3
(Date:6/1/2015)... About Pressure Relief Devices ... and improve the quality life of patients who suffer ... a significant role in inhibiting the growth and treatment ... turn or rotate an immobile patient by providing all ... and specialty beds. These devices have the ability to ...
(Date:6/1/2015)... MECHANICSBURG, Pa. , June 1, 2015 ... announced that MJ Acquisition Corporation, a joint venture that ... Stowe XII, L.P., has completed its previously announced acquisition ... in the new joint venture. About ... leading operator of specialty hospitals and outpatient rehabilitation clinics ...
(Date:6/1/2015)... MENLO PARK, Calif. , June ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, today ... clinical trial of  VAL-083  (dianhydrogalactitol) in patients with ... deadly form of human brain cancer. ...
Breaking Medicine Technology:Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 2DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 3DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 4DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 5DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 6DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 7DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on VAL-083 in Refractory Glioblastoma Multiforme (GBM) at ASCO 8